The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.
In care of MARK Delvaux
Donations are tax-deductible
Category
Other
Employees
19
Volunteers
300
Financial Snapshot
FY ending 2023-06-30
Revenue
$10.5M
Expenses
$8.5M
Assets
$37.7M
Liabilities
$2.2M
Financial history
$10.9M$5.4M$0
2223
RevenueExpenses
Latest FY2023: $10.5M · Peak FY2022: $10.9M
Foreign activity (Schedule F)
Total spent abroad$28K
Foreign employees1
Foreign partnership interestNo
Foreign trust interestNo
Region
Activity
Spent
Europe
—
—
501(h) election
This 501(c)(3) elected the 501(h) safe-harbor — lobbying expenditures are capped under a clear dollar formula instead of the "insubstantial part" standard.